Swedbank AB Has $9.98 Million Stake in Astera Labs, Inc. $ALAB

Swedbank AB increased its position in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 16.5% during the first quarter, HoldingsChannel reports. The fund owned 91,020 shares of the company’s stock after buying an additional 12,880 shares during the quarter. Swedbank AB’s holdings in Astera Labs were worth $9,976,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. Atreides Management LP raised its position in Astera Labs by 2,496.6% in the fourth quarter. Atreides Management LP now owns 1,611,194 shares of the company’s stock valued at $268,038,000 after purchasing an additional 1,549,144 shares during the last quarter. Amundi increased its stake in shares of Astera Labs by 1,298.6% in the third quarter. Amundi now owns 1,421,263 shares of the company’s stock valued at $278,283,000 after buying an additional 1,319,643 shares during the period. Artisan Partners Limited Partnership acquired a new position in shares of Astera Labs in the fourth quarter valued at approximately $148,980,000. Goldman Sachs Group Inc. raised its holdings in Astera Labs by 189.0% in the 4th quarter. Goldman Sachs Group Inc. now owns 1,312,927 shares of the company’s stock valued at $218,419,000 after buying an additional 858,693 shares during the last quarter. Finally, State Street Corp raised its holdings in Astera Labs by 32.5% in the 4th quarter. State Street Corp now owns 3,099,809 shares of the company’s stock valued at $515,684,000 after buying an additional 760,358 shares during the last quarter. Institutional investors and hedge funds own 60.47% of the company’s stock.

Insider Activity at Astera Labs

In other news, COO Sanjay Gajendra sold 400,000 shares of Astera Labs stock in a transaction dated Thursday, May 21st. The stock was sold at an average price of $290.30, for a total value of $116,120,000.00. Following the completion of the transaction, the chief operating officer directly owned 5,064,213 shares of the company’s stock, valued at approximately $1,470,141,033.90. This trade represents a 7.32% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 325,693 shares of Astera Labs stock in a transaction dated Friday, April 17th. The stock was sold at an average price of $172.14, for a total value of $56,064,793.02. Following the completion of the transaction, the chief executive officer directly owned 4,079,322 shares of the company’s stock, valued at approximately $702,214,489.08. This trade represents a 7.39% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 2,040,691 shares of company stock worth $507,675,380 over the last quarter. Company insiders own 10.40% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on ALAB shares. Royal Bank Of Canada lifted their target price on shares of Astera Labs from $250.00 to $270.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 6th. TD Cowen raised their price target on shares of Astera Labs from $140.00 to $225.00 and gave the company a “hold” rating in a research note on Wednesday, May 6th. Roth Capital reiterated a “buy” rating and set a $275.00 price target on shares of Astera Labs in a report on Wednesday, May 6th. Barclays increased their price objective on Astera Labs from $165.00 to $200.00 and gave the company an “equal weight” rating in a report on Thursday, May 7th. Finally, Evercore reaffirmed an “outperform” rating and set a $297.00 target price on shares of Astera Labs in a research report on Tuesday, May 19th. Twelve equities research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company. According to data from MarketBeat.com, Astera Labs presently has a consensus rating of “Moderate Buy” and a consensus target price of $265.75.

Astera Labs Stock Down 1.1%

Astera Labs stock traded down $4.48 during mid-day trading on Friday, hitting $412.97. 2,158,702 shares of the stock were exchanged, compared to its average volume of 5,804,834. The stock has a market capitalization of $70.79 billion, a price-to-earnings ratio of 279.03, a PEG ratio of 4.79 and a beta of 3.66. Astera Labs, Inc. has a 12 month low of $88.18 and a 12 month high of $499.48. The firm’s fifty day simple moving average is $335.76 and its two-hundred day simple moving average is $214.65.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The company had revenue of $308.36 million for the quarter, compared to analyst estimates of $292.19 million. During the same period in the prior year, the firm posted $0.33 EPS. The company’s quarterly revenue was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, analysts forecast that Astera Labs, Inc. will post 1.84 earnings per share for the current fiscal year.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.